Resumo

HERNANDEZ RODRIGUEZ, José; LICEA PUIG, Manuel Emiliano  e  CASTELO ELIAS-CALLES, Lizet. Questions and answers about general aspects of the pharmacotherapy for the obese patients. Rev Cubana Endocrinol [online]. 2013, vol.24, n.2, pp. 214-228. ISSN 1561-2953.

Introduction: through the use of pharnacotherapy in the obese patients, it has been intended to reach bigger and faster weight loses than those reported by the conventional therapeutic methods, all of which undoubtedly facilitates the objective reduction of morbidity and mortality observed in patients suffering this health problem. Objectives: to describe the general aspects of the drug therapy in the obese patient and to mention some of the drugs used. Development: it is important to know the general aspects of the pharmacotherapy for obesity. Considerations on how to select the optimal drug, the general principles of using it, the criteria for the selection of patients and the types of drugs to be avoided in the obese people are key elements to assure a quality medical care. Some well-known products that were prescribed as pharmaco treatment for obesity are not longer in use because of their ineffectiveness or adverse effects. The use of orlistat or xenical should be the most common alternative to treat this disease at present. The recent approval or new drugs such as Lorcaserina (belviq) and qnexa (qsymia) may represent useful options. Conclusions: the knowledge about the general aspects of the pharmacotherapy aimed at obesity is indispensable. The possibility of using new drugs turns out to be a hopeful alternative.

Palavras-chave : obesity; drug treatment; weight loss.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )